<DOC>
	<DOCNO>NCT00518544</DOCNO>
	<brief_summary>Background : Individuals type O blood reduce factor VIII von Willebrand factor level compare non-O counterpart . Infusion hydroxyethyl starch ( HES ) impair coagulation , O blood type , apparent coagulopathy develop HES infusion . A newly market-released balanced HES ( 670/0.75 ) physiologic pH balance electrolyte include calcium , beneficial coagulation . Studies compare balance HES ( 670/0.75 ) saline-based HES ( 130/0.4 ) , previously know least coagulopathic rare . Therefore , try reveal difference coagulation , pH/electrolyte balance , bleed amount non-O O blood type infusion two new HES . Methods : Each 20 non-O type O ASA 1 2 patient schedule spinal surgery involve 2 3 spinal level enrol . 20 ml/kg saline-based HES ( 130/0.4 ) balance HES ( 670/0.75 ) administer operation . Blood loss , coagulation metabolic profile check pre-infusion ( T0 ) , 5 min infusion ( T1 ) , 4 hr infusion ( T2 ) 24 hrs infusion ( T4 ) .</brief_summary>
	<brief_title>Hemostatic Effect Various Colloid Solutions</brief_title>
	<detailed_description />
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Patients ASA 1 2 , schedule posterior laminectomy internal fixation two three spinal level . presence cardiovascular disease , cerebral vascular disease , hepatic , pulmonary , renal disease , hemoglobin &lt; 12 g/dl , platelet count &lt; 150,000 /ml , coagulopathy , take medication likely alter coagulation le 2 week study , allergic reaction HES</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>hydroxyethyl starch , blood type , coagulation</keyword>
</DOC>